RCM Technologies, Inc. is a business and technology solutions provider operating through three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions. The Specialty Health Care segment supplies medical professionals, nurses, therapists, and paraprofessionals to healthcare institutions and school districts in the United States, including teletherapy services for the education sector. The Engineering segment delivers design, consulting, and EPC services across Energy Services, Process & Industrial, and Aerospace verticals, supporting critical infrastructure projects in North America and Europe. The Life Sciences, Data and Solutions segment offers IT infrastructure management, application development, data solutions, and AI-driven process automation for life sciences and other industries. Founded in 1975, the company serves clients in aerospace, defense, energy, financial services, healthcare, and the public sector.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Staffing & Employment Services Homepage rcmt.com
Sector Industrials IR page rcmt.com/investor-relations
Tags
healthcare staffing, engineering services, epc, it infrastructure, data management, teletherapy, process engineering, aerospace engineering, energy services, ai automation, RCM Healthcare Services
Press page rcmt.com/news

Metrics

Valuation  
Market cap $ 290.098M
Market cap (USD) $ 290.098M
P/E 17.16
PEG —
P/BV 5.48
P/S 0.86
P/OCF 13.64
P/FCF 14.09
Dividend yield —
Turnover / mcap —
Returns  
ROE 41.1%
ROI 23.1%
ROIC 26.3%
Profit margin 5.1%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -7.9%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 53.7%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 4
Quality score 5.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998
Revenue 319.404M 278.38M 263.237M 284.68M 203.875M 150.409M 191.1M 200.352M 186.737M 176.448M 185.736M 193.77M 170.778M 145.817M 143.811M 162.022M 171.731M 209.277M 214.209M 201.92M 180.618M 169.277M 206.605M 186.651M — — 313.386M 201.452M
Net profit 16.334M 13.327M 16.831M 20.889M 10.989M -8.869M 4.058M 2.715M 2.01M 1.758M 6.015M 6.814M 1.99M 3.227M 4.278M 5.795M 6.922M -39.805M 6.769M 6.356M 3.536M 2.207M 2.779M — — — 14.948M 9.797M
Free cash flow 17.37M 3.598M 9.551M 27.394M 347K 24.743M -5.145M -1.582M 4.031M 10.789M 9.691M 2.09M -5.198M 3.053M 6.196M 13.239M 15.589M -7.474M 7.98M 4.035M 3.038M -863.579K 2.462M 29.883M — — -7.674M -2.978M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998
Share price 20.45 22.16 29.04 12.34 7.12 2.07 3 3.1 6.27 6.36 5.5 7 6.98 5.55 4.41 4.63 0.9 0.9 — — — — — — — — — —
Price performance 12m -0.08 -0.24 1.35 0.73 2.44 -0.31 -0.03 -0.51 -0.01 0.16 -0.21 0 0.26 0.26 -0.05 4.14 0 — — — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 45.2M 46.1M 52.3M 59.8M 36M 48.2M 50.8M 70.7M 78M —
↳ YoY growth -11.3% +2.0% +13.6% +14.2% -39.7% +34.0% +5.2% +39.3% +10.3%
↳ 5y CAGR +3.0% +1.1% -1.2% +0.2% -6.7% +1.3% +2.0% +6.2% +5.5%
Lease liabilities (USD) — — — 6.56M 4.88M 4.07M 4.98M 3.19M 7.21M 6.25M
Cash and deposits (USD) 279,000 2.85M 482,000 1.85M 734,000 235,000 339,000 6.28M 4.73M 2.92M
Intangible assets (USD) 171,000 105,000 743,000 416,000 95,000 0.00 864,000 683,000 0.00 —
Right-of-use assets (USD) — — — 5.82M 2.41M 1.88M 3.67M 2.78M 5.17M 4.83M
Cash flow detail
Operating cash flow (USD) 11.6M 5.07M -64,000 -4.78M 25.2M 915,000 28.3M 12.5M 6.17M 19M
Purchases of property, plant and equipment (USD) -846,000 -1.04M -1.52M -367,000 -460,000 -568,000 -889,000 -2.93M -2.57M -1.6M
Change in receivables (cash effect) (USD) 5.43M -459,000 -7.68M -7.63M 15.9M -14.7M -1.51M -20.6M -7.27M —
Change in payables (cash effect) (USD) -290,000 -318,000 1.02M -3.09M 1.64M 1.52M 4.92M -1.51M 1.1M -3.48M
Dividends paid (cash effect) (USD) 0.00 -12.2M — — — — — — — —
Share buybacks (cash effect) (USD) -4.26M -365,000 — — -2.23M -9.04M -17.6M -25.8M -7.8M -7.36M
Interest paid (cash effect) (USD) -464,000 -500,000 -1.16M -1.66M -1.03M -417,000 -297,000 -1.19M -2.15M -2.63M
Income taxes paid (cash effect) (USD) -927,000 -522,000 -350,000 -290,000 -264,000 -1.01M -5.1M -4.45M -5.35M -6.11M
Share-based compensation (USD) 901,000 770,000 544,000 806,000 1.11M 1.36M 1.58M 2.09M 2.86M 3.73M
Operating cash flow before change in receivables (USD) 6.21M 5.53M 7.62M 2.85M 9.26M 15.6M 29.8M 33.1M 13.4M —
Free cash flow (OCF - PPE - intangibles) (USD) 10.8M 4.03M -1.58M -5.15M 24.7M 347,000 27.4M 9.55M 3.6M 17.4M
Income detail
Total comprehensive income (USD) 2.03M 2.19M 2.36M 4.07M -8.67M 10.8M 20.7M 16.9M 13.2M 16.4M
Comprehensive income to owners (USD) 2.03M 2.19M 2.36M 4.07M -8.67M 10.8M 20.7M 16.9M 13.2M 16.4M
Provision for credit losses (USD) 616,000 210,000 1.11M 322,000 7.91M -208,000 -1.04M 656,000 -31,000 906,000
Credit cost ratio (credit losses / average receivables) (%) 1.3% 0.5% 2.2% 0.6% 16.5% 0.5% 2.1% 1.1% 0.0% —
Reported Mar 8, 2018 Mar 8, 2018 Mar 11, 2019 Mar 5, 2020 Apr 4, 2022 Apr 4, 2022 Mar 16, 2023 Mar 14, 2024 Mar 13, 2025 Apr 3, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

·

October 21, 2026

Seasonal temperature changes can affect ethanol plant performance in very different ways, particularly for facilities operating near their maximum capacity.

In a new article for Ethanol Producer Magazine , Andrew Cancilla, Process Engineer with RCM Thermal Kinetics, examines how summer heat and winter cold affect distillation, dehydration and evaporation (DD&E) systems, and what those changes can reveal about plant performance.

During hot and humid conditions, higher cooling-water temperatures can reduce the available temperature driving force in condensers, affecting heat rejection and vacuum performance. For plants operating near their capacity limits, performance issues that emerge during the hottest days of the year can help identify where heat-transfer margins are becoming constrained.

Winter can present the opposite challenge. Cooling systems designed for demanding summer conditions may provide substantially more cooling than the process requires as cooling-water temperatures fall. In some DD&E configurations, that can result in significantly subcooled reflux, increasing energy requirements, and reducing separation efficiency.

Andrew also explores how plant configuration affects these seasonal impacts and discusses operational approaches that can help manage winter conditions while preserving the heat-transfer capacity needed during summer operation.

The broader lesson: seasonal extremes can provide useful insight into equipment margins, process efficiency and potential future bottlenecks. Understanding how a DD&E system responds as conditions change can help operators make better-informed decisions around performance, energy consumption and future capacity.

Read the full article, “Understanding Seasonal Impacts on Ethanol DD&E Systems ,” in the November 2026 issue of Ethanol Producer Magazine.

RCM Technologies

Industries of Tomorrow, Today


RCM Technologies, Inc. (Nasdaq: RCMT) is a business and technology solutions provider with world-class talent in key market segments. Operating at the intersection of resources, critical infrastructure, and modernization of industries, RCM is a provider of services in Healthcare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions.

Industries

Company

Careers

Connect

© 2026 RCM Technologies, Inc. All Rights Reserved.

Some areas of this page may shift around if you resize the browser window. Be sure to check heading and document order.

Company Logo

This website uses cookies and other tracking technologies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. If we have detected an opt-out preference signal then it will be honored. Further information is available in our Privacy Policy.

Do Not Sell or Share My Personal Information Reject All Accept Cookies

Company Logo

Do Not Sell or Share My Personal Data

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.
More information

Allow All

Manage Consent Preferences

Strictly Necessary Cookies

Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Share Or Sale of Personal Data

Share Or Sale of Personal Data

Under the CPRA, you have the right to opt-out of the sale or sharing of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale or sharing of personal information by using this toggle switch. If you opt out we will not be able to offer you personalized ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link.If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

  • Targeting Cookies

    Switch Label

    These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

  • Performance Cookies

    Switch Label

    These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Back Button

Cookie List

Search Icon

Filter Icon

Clear

  • checkbox label label

Apply Cancel

Consent Leg.Interest

checkbox label label

checkbox label label

checkbox label label

Reject All Confirm My Choices

Powered by Onetrust

·

October 19, 2026

Throughout our blog series on the evolution of software assurance in the life sciences industry, we’ve examined why life sciences companies are moving from CSV to CSA , how organizational change supports successful adoption , and how training, resourcing, and legacy-system triage can help build a sustainable approach.

This final installment addresses a question that typically follows: Can technology make validation faster and more cost-effective? We believe it can. For that reason, we recommend evaluating an AI-enabled validation tool as part of the transition to CSA rather than treating it as a separate, later initiative.

Here, we examine where the regulatory view of AI stands today, how quickly the underlying technology is changing, why we view AI as part of the CSA transition, and how organizations can put it to work without creating new compliance risks.

The Regulatory Landscape

Although the agencies differ in their specific requirements and timelines, their guidance reflects a consistent direction: AI should be governed according to its intended use, associated risk, and potential impact on product quality and patient safety.

  • FDA CSA guidance (final, September 2025). Already contemplates AI tools used within production and quality systems and applies the same risk-based logic to them as to any other software.
  • FDA draft guidance on AI to support regulatory decision-making for drugs and biologics (January 2025). Introduces a risk-based credibility framework built around the question the AI is answering (its context of use) and the consequence of a wrong answer.
  • FDA and EMA guiding principles for good AI practice (January 2026). Ten joint principles covering AI across the medicines lifecycle, and the clearest signal yet that the two agencies intend to align.
  • EU GMP Annex 22, Artificial Intelligence (draft, July 2025). The first GMP text written specifically for AI. It covers static, deterministic models used in critical applications and states that generative AI and large language models should not be used in critical GMP applications, while allowing them in non-critical uses with a qualified person accountable for the output. EMA held a stakeholder workshop in mid-2026 and is targeting final text in Q4 2026. Revised Annex 11 and Chapter 4 were released for consultation alongside it.
  • EU AI Act. Obligations for high-risk AI systems were moved to December 2027 under the Digital Omnibus agreement. Deferred, not cancelled.
  • ISPE GAMP Guide: Artificial Intelligence (July 2025). The industry’s practical framework for applying GAMP’s risk-based lifecycle to AI-enabled computerized systems.

Taken together, these publications reflect the same principles that underpin CSA: defining intended use, assessing risk, maintaining accountability through qualified personnel, and controlling the system throughout its lifecycle. Organizations that have already adopted CSA are therefore familiar with the risk-based language regulators are applying to AI. Organizations that continue to rely on traditional CSV practices may need to adapt both their validation approach and their AI governance framework.

Expect this list to keep changing. Annex 22 may be revised before it is final, and its position on generative AI is still being debated. The goal is a program that absorbs new guidance without being rebuilt each time: risk-based, with documented rationale and a person in the loop.

The Technology Is Moving Faster Than the Guidance

As quickly as regulation is moving, the technology is moving faster. Model capability now improves in months, not years. Tools that could only summarize a document two years ago can now draft a risk assessment against your own criteria, generate test cases from a requirement, and review executed evidence for gaps. Three shifts matter most for validation teams.

  • AI is being built into the systems you validate. eQMS, LIMS, MES and document management vendors are shipping AI features in routine releases. Each one is a new function with an intended use to define and a risk to assess, and it arrives on the vendor’s schedule, not yours.
  • Release cadence has changed the math. Cloud platforms update several times a year. Under CSV, every release meant an impact assessment and a round of regression scripts. Manual effort does not keep pace with that cadence, even under CSA.
  • AI-enabled validation tools are becoming more capable. Digital validation platforms can now support activities such as drafting documentation, maintaining traceability, and performing preliminary reviews. When implemented with appropriate controls and human oversight, these capabilities can help organizations apply CSA more consistently and at scale.

Selecting an AI-enabled tool is also a change-control decision. Model updates, new features, and configuration changes can affect system behavior. Organizations that manage these changes effectively treat the AI model and its configuration as controlled items: they document the version in use, assess changes, and perform appropriate re-verification when necessary.

Our Position: CSA Without AI Is Not a Recommended Approach

We consistently advise clients to consider an AI-enabled validation tool when transitioning to CSA. CSA changes the scope and focus of assurance activities, while AI can improve the speed and consistency with which those activities are performed. Implementing CSA without the supporting technology may therefore limit the operational benefits of the transition.

  • CSA removes low-value work; AI speeds up the work that remains. Intended use statements, risk assessments, rationale, traceability and evidence review still take time. AI drafts, cross-checks and flags them. People decide. 

  • Consistency is the hardest part of CSA. Part 3 described the calibration problem: trained assessors reaching different ratings for the same system. A tool that applies your documented risk criteria the same way every time gives assessors a consistent starting point and makes outliers visible. 

  • It is where the return actually shows up. The documentation savings from CSA are real, but modest if every step is still manual. The larger return comes from shorter cycle times per system and per release, fewer review loops, and staff time moved to the high-risk functions that deserve it. 

  • AI can improve speed and quality. AI can review large volumes of test evidence without the variability that often accompanies repetitive manual review. It can identify missing traceability, inconsistent terminology, incomplete records, and evidence that does not correspond to the expected result. These are common documentation issues that can contribute to audit or inspection observations. 

  • Doing both together is cheaper than retrofitting. Building new SOPs, templates and training around a manual process, then rebuilding them for a tool a year later, means paying for the transition twice. 

Where AI Fits in the CSA Lifecycle

AI does not replace the CSA process. Instead, it can support specific activities within that process, while qualified personnel remain responsible for risk decisions, acceptance of evidence, and final approval.

CSA Step How AI Can support the Process What Your People Own
Define intended use Drafts intended-use statements from requirements, vendor documentation and process maps; flags gaps and ambiguous functions Confirming the intended use is accurate and complete
Assess risk Proposes a risk rating for each function against your documented criteria, with its reasoning shown Agreeing or overriding the rating and signing the rationale
Plan Assurance Recommends scripted, unscripted or vendor-leveraged assurance by risk; drafts test cases from requirements Approving the plan and the level of rigor
Execute Guides execution in a digital platform, captures evidence automatically, runs automated regression on each release Performing and witnessing high-risk testing; judging unexpected results
Review and record Checks evidence against expected results, traceability and documentation rules; summarizes deviations Final review and approval
Maintain Reads vendor release notes, maps changes to validated functions, drafts the impact assessment; supports periodic review Change-control decisions

Digital Platforms, Unscripted Testing and Vendor Evidence

AI works best on a foundation that is already digital. Three other parts of the technology picture matter as much as the AI itself.

  • Digital validation platforms. Paperless authoring, execution, review and approval, with traceability and Part 11 controls built in. Without one, AI produces drafts that people copy into Word and print. With one, the whole record stays connected, searchable and inspection-ready.
  • Unscripted and exploratory testing tools. CSA explicitly allows unscripted and ad hoc testing for lower-risk functions. Tools that record the session, capture screens and log results automatically turn exploratory testing into defensible evidence without writing scripts first.
  • Vendor evidence. Supplier qualification packages, audit reports and vendor test results can be leveraged under CSA rather than repeated. AI can read those packages and show where the vendor’s testing covers your intended use and where it does not.

Measuring the ROI of CSA and AI

The return from CSA and AI is real, but it has to be measured, not assumed. Part 3 recommended tracking effort explicitly in the first year; that baseline is what proves the case.

Track:

  • Effort. Hours per system and per release, compared with the CSV baseline.
  • Speed. Elapsed time from change request to release approval.
  • Quality. Review cycles per deliverable and documentation errors found in review.
  • Focus. Share of assurance effort spent on high-risk functions.
  • Outcome. Audit and inspection observations on CSA-assured systems.

Expect the implementation pattern described in Part 3: effort will initially increase during tool selection, configuration, and pilot execution before declining below the CSV baseline. The right tool can shorten the transition period and reduce the ongoing level of effort, but it will not eliminate the need for implementation and adoption activities.

Assuring the AI Tool Itself

An AI tool used in validation is itself software used in the quality system, and CSA applies to it. That is not a reason to avoid it; it is a reason to set it up correctly.

  • Define its intended use narrowly. A tool that drafts documents for human review carries a very different risk from one that approves anything. Keep a qualified person accountable for every output, consistent with Annex 22 and the FDA and EMA principles.
  • Control versions and configuration. Know which model version the tool uses, and treat model updates as changes to assess.
  • Put prompts, templates and risk criteria under document control. They shape the output as much as the model does.
  • Protect your data. Confirm where data is processed and retained, and that confidential and GxP data is not used to train public models.
  • Keep an AI inventory. List every AI-enabled tool and every AI feature in your validated systems, with its intended use and risk rating. It is fast becoming one of the first things an auditor asks to see.

A Practical Starting Point

  1. Pick one pilot. Choose a system from the Part 3 triage, ideally one with a vendor upgrade coming.
  2. Select the tool using clear criteria, including its suitability for GxP use, Part 11 controls, transparency of AI-generated outputs, the vendor’s quality-system maturity, and its ability to integrate with the systems already in use.
  3. Assure the tool under CSA. Give it a narrow intended use, a risk assessment and a documented rationale.
  4. Run the pilot side by side and measure. Compare hours, elapsed time and review findings against your current approach.
  5. Update and scale. Build the tool into SOPs, templates and role-based training, then extend it in the order the triage sets.

Closing the Series

Across four parts, the message has been consistent. CSA is FDA’s stated expectation, not a draft concept (Part 1) . It succeeds or fails on culture (Part 2) , and it needs real training, dedicated resources and a disciplined legacy triage (Part 3) . Technology is what turns that effort into lasting speed, consistency and return.

The regulatory framework for AI will continue to evolve, and the underlying technology will advance even more rapidly. Organizations will be better positioned to manage those changes when they have a risk-based CSA program, clear governance, qualified human oversight, and technology that supports controlled, repeatable validation practices.

How RCM Life Sciences Can Help

RCM Life Sciences helps organizations move from traditional CSV to a more efficient, risk-based CSA model without losing control of compliance, quality, or data integrity. Our team brings practical experience across quality, regulatory, computer system validation, eQMS, project management, and digital transformation initiatives, helping clients assess current validation practices, redesign SOPs and templates, define risk-based assurance strategies, train cross-functional teams, and support inspection-ready implementation.

RCM supports organizations at every stage of CSA adoption, including evaluating current practices, updating legacy CSV procedures, implementing regulated systems, and reducing outdated validation documentation. Our team helps develop right-sized, sustainable approaches aligned with FDA expectations and industry best practices while maintaining patient safety and product quality.

Contact us to discuss selecting and implementing AI-enabled validation tools as part of your CSA transition, assuring AI-enabled systems and features, building an AI inventory and governance framework, or measuring the return on your validation program.

RCM Technologies

Industries of Tomorrow, Today


RCM Technologies, Inc. (Nasdaq: RCMT) is a business and technology solutions provider with world-class talent in key market segments. Operating at the intersection of resources, critical infrastructure, and modernization of industries, RCM is a provider of services in Healthcare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions.

Industries

Company

Careers

Connect

© 2026 RCM Technologies, Inc. All Rights Reserved.

Company Logo

This website uses cookies and other tracking technologies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. If we have detected an opt-out preference signal then it will be honored. Further information is available in our Privacy Policy.

Do Not Sell or Share My Personal Information Reject All Accept Cookies

Company Logo

Do Not Sell or Share My Personal Data

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.
More information

Allow All

Manage Consent Preferences

Strictly Necessary Cookies

Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Share Or Sale of Personal Data

Share Or Sale of Personal Data

Under the CPRA, you have the right to opt-out of the sale or sharing of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale or sharing of personal information by using this toggle switch. If you opt out we will not be able to offer you personalized ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link.If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

  • Targeting Cookies

    Switch Label

    These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

  • Performance Cookies

    Switch Label

    These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Back Button

Cookie List

Search Icon

Filter Icon

Clear

  • checkbox label label

Apply Cancel

Consent Leg.Interest

checkbox label label

checkbox label label

checkbox label label

Reject All Confirm My Choices

Powered by Onetrust

Some areas of this page may shift around if you resize the browser window. Be sure to check heading and document order.

·

October 5, 2026

If you have never worked with a healthcare staffing agency, you may have questions about what the process actually looks like. Do you need to apply for a specific job? Are staffing positions always temporary? Who employs you? What happens after you accept an assignment?

The answers can vary depending on the agency, employer, and type of position, but understanding the basic process can make it easier to know what to expect.

RCM’s recruiters work with healthcare and school-based professionals at different stages of their careers, from candidates actively searching for their next position to those who simply want to hear about opportunities that may be a good fit.

Your First Conversation With a Recruiter

The process often starts with a conversation.

If you apply for a specific RCM opening, a recruiter will typically review your resume and reach out for an initial conversation to discuss your experience, qualifications, and the position. If you are exploring your options more generally, the conversation may focus on what you are looking for so the recruiter can identify opportunities that align with your preferences as they become available.

It helps to come prepared with an updated resume and information about your current licenses or certifications. You should also be ready to discuss your availability, preferred location and commute, pay expectations, and the types of positions or settings you are interested in.

Being specific about what matters to you can help your recruiter focus the search. Beyond your professional qualifications, factors such as schedule, preferred setting or patient population, location, availability, and longer-term career goals can all play a role in finding the right opportunity.

Understanding Contract and Direct-Hire Opportunities

One common misconception about staffing agencies is that they only offer short-term temporary work. Depending on the agency and employer, opportunities may include contract, long-term, and permanent/direct hire positions.

With a contract position, you generally work at a client organization while remaining an employee of the staffing agency. For example, professionals are typically employed by RCM while working at one of our partner schools or districts. Some may eventually be hired directly by the district, although most begin as RCM contract employees.

Contract also does not necessarily mean short term. Many RCM school-based contracts last for the entire school year, and some continue for multiple years when there is an ongoing need and a strong fit. Eligible RCM employees working 30 or more hours per week may also qualify for benefits including medical, dental, vision, and a 401(k).

Understanding the employment arrangement before accepting a position is important. Ask your recruiter who will employ you, how long the assignment is expected to last, what benefits may be available, and whether there is a possibility of transitioning to a permanent position.

Finding an Opportunity That Fits

A staffing recruiter can introduce you to positions based on your qualifications and preferences, but you decide which opportunities you want to pursue.

RCM recruiters consider professional experience and qualifications along with practical factors such as location, schedule, preferred setting, pay expectations, availability, and career goals. If there is not a suitable opening when you first connect, your recruiter can stay in touch as needs change and new opportunities become available.

That can be particularly useful if you are open to a setting, you have not previously considered. For example, one RCM recruiter worked with a healthcare professional who had primarily worked in a clinical environment but wanted a different schedule and work environment. After discussing the candidate’s experience and goals, the recruiter introduced a school-based opportunity where those clinical skills could be used to support students.

From Interview to Offer

Once you and your recruiter identify a position you want to pursue, the recruiter may submit your information to the client. If the client would like to meet you, the recruiter coordinates the interview and provides available information about the role, expectations, and what the client may be looking for.

If you receive and accept an offer, the next step is generally onboarding and credentialing.

At RCM, that process can include an onboarding application, offer documentation, employment references, background checks, and other requirements specific to the assignment. What’s required can vary considerably by setting and client, with healthcare facilities and school-based assignments often having different clinical, safety, clearance and documentation needs.

Completing requested paperwork and documentation promptly can help prevent avoidable delays. Your recruiter and other members of the staffing team should also be available to explain requirements, answer questions, and keep you updated throughout the process.

What Happens After You Start an Assignment?

The relationship with a staffing agency should continue throughout your assignment.

At RCM, recruiters remain in contact with professionals during their assignments, including first-day outreach and ongoing check-ins. Recruiters, schedulers, and clinical leadership can also serve as resources when questions arise, while virtual and in-person training may be available to support continued professional development and client safety.

As an assignment approaches its end, the recruiter and scheduling team can also discuss other available opportunities. Being flexible about settings or locations may expand the positions available for a future assignment.

What Is Different About School-Based Staffing?

For healthcare professionals considering their first school-based role, the working environment can look quite different from a hospital or other clinical setting.

School-based assignments generally follow academic calendars, with schedules, holidays, breaks, and assignment dates tied to the school year. Professionals may also collaborate closely with teachers, administrators, families, and multidisciplinary education teams.

Before accepting a school-based position, ask about the expected schedule and hours, caseload or responsibilities, assignment length, documentation requirements, school closures and breaks, and the support available at the school.

Professionals moving from clinical environments also commonly want to understand how their experience will translate to working with students. Depending on the role, RCM can provide guidance on the school environment, expectations, documentation, and transitioning existing skills into an education setting.

Questions to Ask a Staffing Recruiter

The recruiter relationship works best when communication goes both ways. Candidates should feel comfortable asking questions and being clear about their priorities.

Before pursuing or accepting an opportunity, consider asking about:

  • Pay and benefits
  • Schedule and expected hours
  • Location and commute
  • Assignment or contract length
  • Day-to-day responsibilities
  • Credentialing and onboarding requirements
  • Support available during the assignment
  • What happens when the assignment ends

The RCM recruiters who contributed to this article consistently pointed to communication and transparency as important parts of a successful recruiter-candidate relationship. Candidates who are clear about their goals, availability, experience, and preferences give recruiters a better understanding of what they are looking for, while recruiters should provide clear information, follow through, and keep candidates informed throughout the process.

Find Your Next Opportunity With RCM

Working with a staffing agency can give you another resource in your career search, whether you are actively looking for your next role, considering a different healthcare or education setting, or simply interested in learning what opportunities are available.

RCM works with healthcare and school-based professionals across a range of specialties and settings. Our recruiting team can help you explore opportunities, understand the hiring and onboarding process, and stay connected throughout your assignment.

Explore current opportunities with RCM Healthcare Services.

RCM Technologies

Industries of Tomorrow, Today


RCM Technologies, Inc. (Nasdaq: RCMT) is a business and technology solutions provider with world-class talent in key market segments. Operating at the intersection of resources, critical infrastructure, and modernization of industries, RCM is a provider of services in Healthcare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions.

Industries

Company

Careers

Connect

© 2026 RCM Technologies, Inc. All Rights Reserved.

Some areas of this page may shift around if you resize the browser window. Be sure to check heading and document order.

Company Logo

This website uses cookies and other tracking technologies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. If we have detected an opt-out preference signal then it will be honored. Further information is available in our Privacy Policy.

Do Not Sell or Share My Personal Information Reject All Accept Cookies

Company Logo

Do Not Sell or Share My Personal Data

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.
More information

Allow All

Manage Consent Preferences

Strictly Necessary Cookies

Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Share Or Sale of Personal Data

Share Or Sale of Personal Data

Under the CPRA, you have the right to opt-out of the sale or sharing of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale or sharing of personal information by using this toggle switch. If you opt out we will not be able to offer you personalized ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link.If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

  • Targeting Cookies

    Switch Label

    These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

  • Performance Cookies

    Switch Label

    These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Back Button

Cookie List

Search Icon

Filter Icon

Clear

  • checkbox label label

Apply Cancel

Consent Leg.Interest

checkbox label label

checkbox label label

checkbox label label

Reject All Confirm My Choices

Powered by Onetrust

Prompts

RCM Technologies, Inc. (ticker RCMT), listed in United States.

ETFs Holding RCM Technologies, Inc.

ETF Weight in ETF Shares Market value As of
MGMT 1.52% 96,195 $ 2.716M Jun 30, 2026
IVSS 0.03% 308 $ 8,694.84 Jun 30, 2026
AVSC 0.01% 7,072 $ 224.395K Nov 16, 2026
DFAS 0.01% 53,212 $ 1.674M Nov 12, 2026
EBI 0.00% 735 $ 30.576K Aug 31, 2026
DXUV 0.00% 3,731 $ 117.377K Nov 12, 2026
DFSU 0.00% 723 $ 22.746K Nov 12, 2026
DCOR 0.00% 11,988 $ 377.142K Nov 12, 2026
DFUV 0.00% 3,924 $ 123.449K Nov 12, 2026
DFAC 0.00% 19,717 $ 620.297K Nov 12, 2026
DFAU 0.00% 764 $ 24.035K Nov 12, 2026
DFUS 0.00% 1,243 $ 39.105K Nov 12, 2026
AVSU 0.00% 11 $ 349.03 Nov 16, 2026